Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development
Similar Names for Similar Biologics
Optimisation of Omalizumab Dosage in Patients with Severe Persistent Allergic Asthma Using recovery ELISA
Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin®)
Making Choices: Health Consumers, Regulation and the Global Stem Cell Therapy Market
Elosulfase Alfa: A Review of Its Use in Patients with Mucopolysaccharidosis Type IVA (Morquio A Syndrome)